The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C.

Caorsi R, Consolaro A, Speziani C, Sozeri B, Ulu K, Faugier-Fuentes E, Menchaca-Aguayo H, Ozen S, Sener S, Akhter Rahman S, Imnul Islam M, Haerynck F, Simonini G, Mastri MV, Avcin T, Sršen S, de Albuquerque Pedrosa Fernandes T, Stanevicha V, Vojinovic J, Sobh A, Fingerhutova S, Minxova L, Gagro A, Rodrigues Fonseca A, Pandya D, Varbanova B, Sánchez-Manubens J, Ganeva M, Montin D, Boyarchuk O, Minghini A, Bracaglia C, Brogan P, Candotti F, Cattalini M, Meyts I, Minoia F, Taddio A, Wouters C, De Benedetti F, Bovis F, Ravelli A, Ruperto N, Gattorno M, HyperPED-COVID study group, ERN-RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases), PReS (Pediatric Rheumatology European Society), ESID (European Society for Immunodeficiencies), ISSAID (International Society of Systemic Auto-Inflammatory Diseases) and the, **Paediatric Rheumatology International Trials Organisation (PRINTO), Bilginer Y, Laila K, Islam MM, Meertens B, Hoste L, Dehoorne J, Schelstraete P, Vandekerckhove K, Willems J, Matthijs I, Filocamo E Gisella Beatrice Beretta G, Magalhaes CS, Chubata O, Ricci F, Vukovic A, Temelkova K, Avramovic MZ, Emersic N, Bizjak M, Vesel T, Rodrigues MF, Gasparello de Almeida R, Lukjanovica K, Elnagdy MH, Soliman A, Terifajova E, Brejchova I, Magner M, Myrup C, Vougiouka O, Jelusic M, La Torre F, Rigante D, Maggio MC, Verdoni L, Rubio-Perez N, Cornejo GV, Villarreal Trevino AV, Brito I, Oliveira-Ramos F, Alexeeva E, Chasnyk V, Arkachaisri T, Boyko Y, Vyzhga Y, Samsonenko S.

Open source

DOI: 10.1016/j.jaut.2024.103265
Published: 2024-06-04
Container: J Autoimmun
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jaut.2024.103265,
  title = {The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C.},
  author = {Caorsi R and  Consolaro A and  Speziani C and  Sozeri B and  Ulu K and  Faugier-Fuentes E and  Menchaca-Aguayo H and  Ozen S and  Sener S and  Akhter Rahman S and  Imnul Islam M and  Haerynck F and  Simonini G and  Mastri MV and  Avcin T and  Sršen S and  de Albuquerque Pedrosa Fernandes T and  Stanevicha V and  Vojinovic J and  Sobh A and  Fingerhutova S and  Minxova L and  Gagro A and  Rodrigues Fonseca A and  Pandya D and  Varbanova B and  Sánchez-Manubens J and  Ganeva M and  Montin D and  Boyarchuk O and  Minghini A and  Bracaglia C and  Brogan P and  Candotti F and  Cattalini M and  Meyts I and  Minoia F and  Taddio A and  Wouters C and  De Benedetti F and  Bovis F and  Ravelli A and  Ruperto N and  Gattorno M and  HyperPED-COVID study group and  ERN-RITA (European Reference Network for Rare Immunodeficiency and  Autoinflammatory and Autoimmune Diseases) and  PReS (Pediatric Rheumatology European Society) and  ESID (European Society for Immunodeficiencies) and  ISSAID (International Society of Systemic Auto-Inflammatory Diseases) and the and  **Paediatric Rheumatology International Trials Organisation (PRINTO) and  Bilginer Y and  Laila K and  Islam MM and  Meertens B and  Hoste L and  Dehoorne J and  Schelstraete P and  Vandekerckhove K and  Willems J and  Matthijs I and  Filocamo E Gisella Beatrice Beretta G and  Magalhaes CS and  Chubata O and  Ricci F and  Vukovic A and  Temelkova K and  Avramovic MZ and  Emersic N and  Bizjak M and  Vesel T and  Rodrigues MF and  Gasparello de Almeida R and  Lukjanovica K and  Elnagdy MH and  Soliman A and  Terifajova E and  Brejchova I and  Magner M and  Myrup C and  Vougiouka O and  Jelusic M and  La Torre F and  Rigante D and  Maggio MC and  Verdoni L and  Rubio-Perez N and  Cornejo GV and  Villarreal Trevino AV and  Brito I and  Oliveira-Ramos F and  Alexeeva E and  Chasnyk V and  Arkachaisri T and  Boyko Y and  Vyzhga Y and  Samsonenko S.},
  year = {2024},
  journal = {J Autoimmun},
  doi = {10.1016/j.jaut.2024.103265},
  url = {https://doi.org/10.1016/j.jaut.2024.103265}
}

RIS

TY  - JOUR
TI  - The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C.
AU  - Caorsi R
AU  -  Consolaro A
AU  -  Speziani C
AU  -  Sozeri B
AU  -  Ulu K
AU  -  Faugier-Fuentes E
AU  -  Menchaca-Aguayo H
AU  -  Ozen S
AU  -  Sener S
AU  -  Akhter Rahman S
AU  -  Imnul Islam M
AU  -  Haerynck F
AU  -  Simonini G
AU  -  Mastri MV
AU  -  Avcin T
AU  -  Sršen S
AU  -  de Albuquerque Pedrosa Fernandes T
AU  -  Stanevicha V
AU  -  Vojinovic J
AU  -  Sobh A
AU  -  Fingerhutova S
AU  -  Minxova L
AU  -  Gagro A
AU  -  Rodrigues Fonseca A
AU  -  Pandya D
AU  -  Varbanova B
AU  -  Sánchez-Manubens J
AU  -  Ganeva M
AU  -  Montin D
AU  -  Boyarchuk O
AU  -  Minghini A
AU  -  Bracaglia C
AU  -  Brogan P
AU  -  Candotti F
AU  -  Cattalini M
AU  -  Meyts I
AU  -  Minoia F
AU  -  Taddio A
AU  -  Wouters C
AU  -  De Benedetti F
AU  -  Bovis F
AU  -  Ravelli A
AU  -  Ruperto N
AU  -  Gattorno M
AU  -  HyperPED-COVID study group
AU  -  ERN-RITA (European Reference Network for Rare Immunodeficiency
AU  -  Autoinflammatory and Autoimmune Diseases)
AU  -  PReS (Pediatric Rheumatology European Society)
AU  -  ESID (European Society for Immunodeficiencies)
AU  -  ISSAID (International Society of Systemic Auto-Inflammatory Diseases) and the
AU  -  **Paediatric Rheumatology International Trials Organisation (PRINTO)
AU  -  Bilginer Y
AU  -  Laila K
AU  -  Islam MM
AU  -  Meertens B
AU  -  Hoste L
AU  -  Dehoorne J
AU  -  Schelstraete P
AU  -  Vandekerckhove K
AU  -  Willems J
AU  -  Matthijs I
AU  -  Filocamo E Gisella Beatrice Beretta G
AU  -  Magalhaes CS
AU  -  Chubata O
AU  -  Ricci F
AU  -  Vukovic A
AU  -  Temelkova K
AU  -  Avramovic MZ
AU  -  Emersic N
AU  -  Bizjak M
AU  -  Vesel T
AU  -  Rodrigues MF
AU  -  Gasparello de Almeida R
AU  -  Lukjanovica K
AU  -  Elnagdy MH
AU  -  Soliman A
AU  -  Terifajova E
AU  -  Brejchova I
AU  -  Magner M
AU  -  Myrup C
AU  -  Vougiouka O
AU  -  Jelusic M
AU  -  La Torre F
AU  -  Rigante D
AU  -  Maggio MC
AU  -  Verdoni L
AU  -  Rubio-Perez N
AU  -  Cornejo GV
AU  -  Villarreal Trevino AV
AU  -  Brito I
AU  -  Oliveira-Ramos F
AU  -  Alexeeva E
AU  -  Chasnyk V
AU  -  Arkachaisri T
AU  -  Boyko Y
AU  -  Vyzhga Y
AU  -  Samsonenko S.
PY  - 2024
JO  - J Autoimmun
DO  - 10.1016/j.jaut.2024.103265
UR  - https://doi.org/10.1016/j.jaut.2024.103265
ER  -

APA

R, C., A, C., C, S., B, S., K, U., E, F., H, M., S, O., S, S., S, A. R., M, I. I., F, H., G, S., MV, M., T, A., S, S., T, D. A. P. F., V, S., J, V., A, S., S, F., L, M., A, G., A, R. F., D, P., B, V., J, S., M, G., D, M., O, B., A, M., C, B., P, B., F, C., M, C., I, M., F, M., A, T., C, W., F, D. B., F, B., A, R., N, R., M, G., group, H. S., Immunodeficiency, E. (. R. N. F. R., Diseases), A. A. A., Society), P. (. R. E., Immunodeficiencies), E. (. S. F., the, I. (. S. O. S. A. D. A., (PRINTO), *. R. I. T. O., Y, B., K, L., MM, I., B, M., L, H., J, D., P, S., K, V., J, W., I, M., G, F. E. G. B. B., CS, M., O, C., F, R., A, V., K, T., MZ, A., N, E., M, B., T, V., MF, R., R, G. D. A., K, L., MH, E., A, S., E, T., I, B., M, M., C, M., O, V., M, J., F, L. T., D, R., MC, M., L, V., N, R., GV, C., AV, V. T., I, B., F, O., E, A., V, C., T, A., Y, B., Y, V., & S., S. (2024). The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C.. J Autoimmun. https://doi.org/10.1016/j.jaut.2024.103265

Source records

europe-pmc · retrieved 2026-09-27T02:30:02.822Z